Invention Grant
- Patent Title: Methods and compositions for treating retina-associated disease using CCR3-inhibitors
-
Application No.: US16603084Application Date: 2018-04-04
-
Publication No.: US11590118B2Publication Date: 2023-02-28
- Inventor: Laura Corradini , Sam Jackson , Karoly Nikolich
- Applicant: ALKAHEST INC.
- Applicant Address: US CA San Carlos
- Assignee: ALKAHEST INC.
- Current Assignee: ALKAHEST INC.
- Current Assignee Address: US CA San Carlos
- Agency: Marshall, Gerstein & Borun LLP
- International Application: PCT/US2018/026091 WO 20180404
- International Announcement: WO2018/187473 WO 20181011
- Main IPC: A61K31/4545
- IPC: A61K31/4545 ; A61K31/5377 ; A61K45/06 ; A61K9/20 ; A61K9/28
Abstract:
Methods of improving visual endpoints related to retina-associated disease with CCR3 modulating agents are provided. An example of such an endpoint is visual acuity. Retina-associated diseases upon which visual acuity and other visual endpoints may be improved include retinopathy of prematurity, age-related macular degeneration, central retinal vein occlusion, and diabetic retinopathy.
Public/Granted literature
- US20210106577A1 METHODS AND COMPOSITIONS FOR TREATING RETINA-ASSOCIATED DISEASE USING CCR3-INHIBITORS Public/Granted day:2021-04-15
Information query
IPC分类:
